세계의 융모성 성선 자극 호르몬 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Chorionic Gonadotropin Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

US $ 4,490 ￦ 6,290,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,091,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,893,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

융모성 성선 자극 호르몬 시장 규모는 향후 몇 년간 안정적인 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 불임 문제의 증가, 생식 건강에 대한 인식의 제고, 보조 생식 기술의 채택 증가, 노인의 성선 기능 저하증의 유병률 증가, 의료 인프라의 확장에 기인할 수 있습니다. 예측 기간 동안의 주요 동향으로는 기술 발전, 재조합 기술의 발전, 보조 생식 기술의 성장, 연구 개발에 대한 투자, 의약품 전달 시스템 및 제형에 대한 혁신이 있습니다.

불임 문제의 유병률 증가는 융모성 성선 자극 호르몬(hCG) 시장의 성장을 촉진할 것으로 예상됩니다. 불임은 35세 미만의 부부가 1년 동안 정기적으로 피임하지 않고 성관계를 가졌지만 임신이 되지 않는 경우, 또는 35세 이상의 부부가 6개월 동안 정기적으로 피임하지 않고 성관계를 가졌지만 임신이 되지 않는 경우로 정의됩니다. 불임의 증가는 많은 사람들이 늦게 아이를 갖기로 선택하는 등 출산 연령이 늦어지고, 비만 및 흡연과 같은 생식 건강에 부정적인 영향을 미치는 생활 습관 요인이 원인으로 지목되고 있습니다. 융모성 성선 자극 호르몬은 불임 치료에 사용되어 배란을 유도하고, 황체기를 지원하며, 남성의 테스토스테론 생성을 촉진합니다. 예를 들어, 세계보건기구(WHO)는 2023년 4월, 성인 인구의 17.5%, 즉 전 세계 인구의 6명 중 1명이 불임으로 고통받고 있다고 발표하며, 불임 치료에 대한 수요가 증가하고 있음을 강조했습니다. 따라서 불임 문제의 유병률이 증가하면서 융모성 성선 자극 호르몬 시장의 성장이 촉진되고 있습니다.

보조 생식 기술(ART)의 증가로 융모성 성선 자극 호르몬 시장의 성장이 가속화될 것으로 예상됩니다. ART에는 개인이나 부부가 임신을 달성할 수 있도록 돕는 체외 수정(IVF)과 같은 의료 절차가 포함됩니다. ART의 증가는 불임률의 증가, 의학의 발전, 출산 연령의 지연에 의해 촉진되고 있습니다. 융모성 성선 자극 호르몬은 ART에서 배란을 촉진하고 배아 이식 후 황체기를 지원하는 데 중요한 역할을 합니다. MJH Life Sciences에 따르면, ART 사이클 수는 크게 증가했으며, 특히 난자 동결 사이클은 2021년 2만 4,560건에서 2022년 2만 9,803건으로 증가했습니다. ART가 계속 확대됨에 따라 융모성 성선 자극 호르몬에 대한 수요도 증가할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 바이오의약품 시장에서의 제품 특성

• 분자 유형
• 투여경로(ROA)
• 작용기전(MOA)
• 안전성과 유효성

제4장 시장 동향과 전략

제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제6장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 융모성 성선 자극 호르몬 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 융모성 성선 자극 호르몬 시장 : 성장률 분석
• 세계의 융모성 성선 자극 호르몬 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 융모성 성선 자극 호르몬 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 융모성 성선 자극 호르몬 : 전체 시장 규모(TAM)

제7장 세계 시장의 가격 분석과 예측

제8장 시장 세분화

• 세계의 융모성 성선 자극 호르몬 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 인간용 융모성 성선 자극 호르몬
• 동물용 융모성 성선 자극 호르몬
• 세계의 융모성 성선 자극 호르몬 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 소매 약국
• 온라인 약국
• 세계의 융모성 성선 자극 호르몬 시장 : 치료 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 남성 성선 기능 저하증
• 여성 불임 치료
• 정자 감소증 치료
• 정류 고환 치료
• 만성 통증
• 기타
• 세계의 융모성 성선 자극 호르몬 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 연구기관
• 제약회사

제9장 임상적응증 세계 시장 역학

• 약제의 부작용
• 임상적응증의 발병률과 유병률

제10장 지역별, 국가별 분석

• 세계의 융모성 성선 자극 호르몬 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 융모성 성선 자극 호르몬 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 한국 시장

제17장 서유럽 시장

제18장 영국 시장

제19장 독일 시장

제20장 프랑스 시장

제21장 동유럽 시장

제22장 북미 시장

제23장 미국 시장

제24장 캐나다 시장

제25장 남미 시장

제26장 중동 시장

제27장 아프리카 시장

제28장 경쟁 구도와 기업 프로파일

• 융모성 성선 자극 호르몬 시장 : 경쟁 구도
• 융모성 성선 자극 호르몬 시장 : 기업 프로파일
  • Ferring Pharmaceuticals

제29장 세계 시장 : 파이프라인 분석

제30장 세계 시장 경쟁 벤치마킹과 대시보드

제31장 주요 인수합병(M&A)

제32장 최근 시장 동향

제33장 시장의 잠재력이 높은 국가, 전략

• 융모성 성선 자극 호르몬 시장(2029년) : 새로운 기회를 제공하는 국가
• 융모성 성선 자극 호르몬 시장(2029년) : 새로운 기회를 제공하는 부문
• 융모성 성선 자극 호르몬 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제34장 부록

HBR

영문 목차

영문목차

Chorionic gonadotropin, specifically human chorionic gonadotropin (hCG), is a hormone produced by the placenta during pregnancy. It helps maintain progesterone levels by supporting the corpus luteum. hCG is used in medical treatments to induce ovulation in women, treat hypogonadism in men, and as a tumor marker for certain cancers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of chorionic gonadotropin are human chorionic gonadotropin and animal chorionic gonadotropin. Human chorionic gonadotropin (hCG) is primarily produced during pregnancy by cells in the placenta, which nourish the fertilized egg after it attaches to the uterine wall. It is distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies, for therapeutic applications such as male hypogonadism, female infertility treatment, oligospermic treatment, cryptorchidism treatment, chronic pain, and others. End users include research institutions and pharmaceutical companies.

The chorionic gonadotropin market research report is one of a series of new reports from The Business Research Company that provides chorionic gonadotropin market statistics, including chorionic gonadotropin industry global market size, regional shares, competitors with a chorionic gonadotropin market share, detailed chorionic gonadotropin market segments, market trends and opportunities, and any further data you may need to thrive in the chorionic gonadotropin industry. This chorionic gonadotropin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chorionic gonadotropin market size is expected to see steady growth in the next few years. It will grow to $1,710 million in 2029 at a compound annual growth rate (CAGR) of 4%. The growth in the forecast period can be attributed to increasing prevalence of infertility issues, rising awareness about reproductive health, increasing adoption of assisted reproductive technologies, rising prevalence of hypogonadism among the elderly, and expanding healthcare infrastructure. Major trends in the forecast period include technological advancements, advancements in recombinant technology, growth in assisted reproductive technology, investments in research and development, and innovations in drug delivery systems and formulations.

Increasing prevalence of infertility issues is expected to drive the growth of the chorionic gonadotropin (hCG) market. Infertility is defined as the inability to conceive after one year of regular, unprotected intercourse for couples under 35, or after six months for those 35 and older. The rise in infertility is attributed to delayed childbearing, as many individuals choose to have children later in life, as well as lifestyle factors like obesity and smoking, which negatively impact reproductive health. Chorionic gonadotropin is used in fertility treatments to induce ovulation, support the luteal phase, and stimulate testosterone production in men. For example, the World Health Organization (WHO) reported in April 2023 that 17.5% of the adult population, or 1 in 6 people globally, experience infertility, highlighting the growing demand for fertility treatments. Therefore, the increasing prevalence of infertility issues is driving the growth of the chorionic gonadotropin market.

An increase in assisted reproductive technologies (ART) is expected to propel the growth of the chorionic gonadotropin market. ART includes medical procedures like in-vitro fertilization (IVF) that help individuals or couples achieve pregnancy. The rise in ART is driven by higher infertility rates, medical advancements, and delayed childbearing. Chorionic gonadotropin plays a crucial role in ART by triggering ovulation and supporting the luteal phase after embryo transfer. According to MJH Life Sciences, the number of ART cycles performed increased significantly, with egg freezing cycles rising from 24,560 in 2021 to 29,803 in 2022. As ART continues to expand, the demand for chorionic gonadotropin is also expected to grow.

A key trend in the chorionic gonadotropin market is the development of innovative solutions, such as saliva-based pregnancy tests, to improve convenience, accuracy, and accessibility. Saliva-based pregnancy tests detect the presence of hCG in saliva, offering a non-invasive and more comfortable alternative to traditional urine-based tests. In June 2023, Salignostics, an Israel-based biotech company, launched the world's first saliva-based pregnancy test, Salistick. This product enables women to determine pregnancy using a saliva sample, with results available in 5 to 15 minutes, providing a more convenient and discreet testing experience.

Key player operating in the chorionic gonadotropin market is Ferring Pharmaceuticalss.

North America was the largest region in the chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chorionic gonadotropin report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chorionic gonadotropin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chorionic gonadotropin market consists of sales of products including follicle-stimulating hormone, luteinizing hormone, menotropins, gonadotropin-releasing hormone, and clomiphene citrate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chorionic Gonadotropin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chorionic gonadotropin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chorionic gonadotropin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chorionic gonadotropin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Human Chorionic Gonadotropin; Animal Chorionic Gonadotropin
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 3) By Therapeutic Application: Male Hypogonadism; Female Infertility Treatment; Oligospermic Treatment; Cryptorchidism Treatment; Chronic Pain; Other Therapeutic Applications
• 4) By End User: Research Institutions; Pharmaceutical Companies
• Companies Mentioned: Ferring Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chorionic Gonadotropin Market Characteristics

3. Chorionic Gonadotropin Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Chorionic Gonadotropin Market Trends And Strategies

5. Chorionic Gonadotropin Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Chorionic Gonadotropin Growth Analysis And Strategic Analysis Framework

• 6.1. Global Chorionic Gonadotropin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Chorionic Gonadotropin Market Growth Rate Analysis
• 6.4. Global Chorionic Gonadotropin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Chorionic Gonadotropin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Chorionic Gonadotropin Total Addressable Market (TAM)

7. Global Chorionic Gonadotropin Market Pricing Analysis & Forecasts

8. Chorionic Gonadotropin Market Segmentation

• 8.1. Global Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Chorionic Gonadotropin
• Animal Chorionic Gonadotropin
• 8.2. Global Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 8.3. Global Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Male Hypogonadism
• Female Infertility Treatment
• Oligospermic Treatment
• Cryptorchidism Treatment
• Chronic Pain
• Other Therapeutic Applications
• 8.4. Global Chorionic Gonadotropin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Institutions
• Pharmaceutical Companies

9. Global Chorionic Gonadotropin Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Chorionic Gonadotropin Market Regional And Country Analysis

• 10.1. Global Chorionic Gonadotropin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Chorionic Gonadotropin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Chorionic Gonadotropin Market

• 11.1. Asia-Pacific Chorionic Gonadotropin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Chorionic Gonadotropin Market

• 12.1. China Chorionic Gonadotropin Market Overview
• 12.2. China Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Chorionic Gonadotropin Market

• 13.1. India Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Chorionic Gonadotropin Market

• 14.1. Japan Chorionic Gonadotropin Market Overview
• 14.2. Japan Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Chorionic Gonadotropin Market

• 15.1. Australia Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Chorionic Gonadotropin Market

• 16.1. South Korea Chorionic Gonadotropin Market Overview
• 16.2. South Korea Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Chorionic Gonadotropin Market

• 17.1. Western Europe Chorionic Gonadotropin Market Overview
• 17.2. Western Europe Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Chorionic Gonadotropin Market

• 18.1. UK Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Chorionic Gonadotropin Market

• 19.1. Germany Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Chorionic Gonadotropin Market

• 20.1. France Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chorionic Gonadotropin Market

• 21.1. Eastern Europe Chorionic Gonadotropin Market Overview
• 21.2. Eastern Europe Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Chorionic Gonadotropin Market

• 22.1. North America Chorionic Gonadotropin Market Overview
• 22.2. North America Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Chorionic Gonadotropin Market

• 23.1. USA Chorionic Gonadotropin Market Overview
• 23.2. USA Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Chorionic Gonadotropin Market

• 24.1. Canada Chorionic Gonadotropin Market Overview
• 24.2. Canada Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Chorionic Gonadotropin Market

• 25.1. South America Chorionic Gonadotropin Market Overview
• 25.2. South America Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Chorionic Gonadotropin Market

• 26.1. Middle East Chorionic Gonadotropin Market Overview
• 26.2. Middle East Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Chorionic Gonadotropin Market

• 27.1. Africa Chorionic Gonadotropin Market Overview
• 27.2. Africa Chorionic Gonadotropin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Chorionic Gonadotropin Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Chorionic Gonadotropin Market Competitive Landscape And Company Profiles

• 28.1. Chorionic Gonadotropin Market Competitive Landscape
• 28.2. Chorionic Gonadotropin Market Company Profiles
  • 28.2.1. Ferring Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

29. Global Chorionic Gonadotropin Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Chorionic Gonadotropin Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Chorionic Gonadotropin Market

32. Recent Developments In The Chorionic Gonadotropin Market

33. Chorionic Gonadotropin Market High Potential Countries, Segments and Strategies

• 33.1 Chorionic Gonadotropin Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Chorionic Gonadotropin Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Chorionic Gonadotropin Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer

관련자료